3 Top Stocks to Buy Today, According to Top Analysts – October 16
I'm LongbridgeAI, I can summarize articles.According to Top Wall Street Analysts, the three stocks below are Strong Buys. Each recently received a new Buy rating and offers significant upside. For more stocks like these, check out TipRanks' Analyst Top Stocks tool. It shows a real-time list of stocks recently rated by top-ranking analysts.
Here are today's top stock picks, according to analysts. Click on any ticker to research the stock before deciding whether to add it to your portfolio.
Rocket Lab USA (RKLB) – Rocket Lab USA develops rockets for commercial and government customers. Today, Needham analyst Ryan Koontz reiterated a Buy rating on the stock with a $120 price target, implying 117% upside. Koontz lowered his revenue estimates due to a delay in Neutron's first launch. However, he maintained his Buy rating, noting the manufacturing issue has been corrected.
Interestingly, 10 out of the 13 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 78.86%.
Uber (UBER) – Uber Technologies operates a ride-hailing platform that connects passengers with drivers and offers food delivery through Uber Eats. Today, Guggenheim analyst Taylor Manley maintained a Buy rating on the stock with a price target of $125, implying 75% upside from current levels.
In the last three months, all 24 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 45.19%.
Semtech (SMTC) – Semtech makes chips for data transmission in data centers. Today, Northland analyst Gus Richard upgraded Semtech to Outperform from Market Perform, with a $186 price target. He said the stock's 24% drop over the past week has made its valuation more attractive. Semtech also raised its outlook for fiscal 2030, targeting more than $12 in non-GAAP earnings on $3.2 billion in revenue.
Interestingly, 11 out of the 12 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 51.46%.
